Business

Gaming Innovation Group expands strategic commercial partnership with News UK

ST JULIANS, Malta., Feb. 23, 2023 /PRNewswire/ -- Gaming Innovation Group Inc. (GiG) has expanded its commercial partnership with News Corp UK & Ireland...

Calliditas – Year-End Report, 2022

2022: Successful transformation into a commercial stage company STOCKHOLM, Feb. 23, 2023 /PRNewswire/ --  "2022 was a fantastic year for Calliditas as we launched TARPEYO® in...

Lundin Mining Announces Declaration of Regular Dividend

TORONTO, Feb. 22, 2023 /PRNewswire/ -- (TSX: LUN) (Nasdaq Stockholm: LUMI) Lundin Mining Corporation ("Lundin Mining" or the "Company") today announced that its Board of Directors...

Steinberg Diagnostics Celebrates 35 Years Serving Las Vegas

LAS VEGAS, Feb. 22, 2023 /PRNewswire/ -- In 1988 Dr. Leon Steinberg, Dr. David Steinberg, and Dr. Mark Winkler watched as the construction of...

Spirit of Steve Jobs Lives on in Demo of New Safe-for-Work, AI-assisted Product Creation Studio and Community of Promptmasters

Design community given a new home at the celebration of Steve's birthday. SAN FRANCISCO, Feb. 21, 2023 /PRNewswire/ -- roses/foundation announced rose emoji dot fm slash...

Strength in North America delivers revenue growth as new strategic focus takes root: Catena Media

STOCKHOLM, Feb. 22, 2023 /PRNewswire/ -- Catena Media plc Year-end Report January – December 2022 Highlights            Revenue increased by 31 percent in North America in Q4, led...

5N Plus Reports 2022 Fourth Quarter and Annual Financial Results

Provides Adjusted EBITDA1 Guidance for FY 2023 and FY 2024 MONTRÉAL, Feb. 21, 2023 /CNW/ - 5N Plus Inc. (TSX: VNP) ("5N Plus" or the "Company"), a leading global producer of specialty semiconductors and performance materials, today announced...

Anovion and Forge Nano Sign Offtake Agreement for the Supply of Synthetic Graphite Anode Powders Optimized With Atomic Armor™ for Next-Generation Lithium-Ion Batteries

Proprietary technology enables improved performance with increased life cycle, reduced capacity fade and stability of lithium-ion batteries. CHICAGO and DENVER, Feb. 21, 2023 /PRNewswire/ -- Anovion, an...

FDA Accepts Orasis Pharmaceuticals' New Drug Application for CSF-1 for the Treatment of Presbyopia

- Investigational, novel eye drop candidate was assigned PDUFA goal date of October 22, 2023 PONTE VEDRA, Fla., Feb. 21, 2023 /PRNewswire/ -- Orasis Pharmaceuticals,...

Latest articles